Andrew Retter - 01 Nov 2025 Form 4 Insider Report for VOLITIONRX LTD (VNRX)

Reporting relationship: Chief Medical Officer
Issuer ticker: VNRX
Reported as of: 01 Nov 2025
Net transaction value: -$1,991
SEC form: 4
Accepted by SEC: 04 Nov 2025, 16:01:54 UTC
Prior SEC filing: 19 Aug 2025
Source filing: View source filing
Reporting owner signature: /s/ Andrew Retter

Key filing fact

Andrew Retter filed Form 4 for VOLITIONRX LTD (VNRX) on 04 Nov 2025.

Key facts

This page summarizes Andrew Retter's Form 4 filing for VOLITIONRX LTD (VNRX).
1 reported transaction and 0 derivative rows are listed below.
Accepted by SEC: 04 Nov 2025, 16:01.

Change

Previous filing in this sequence was filed on 19 Aug 2025.
Current net transaction value: -$1,991.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0002015252 Primary reporting owner

Retter Andrew

Relationship: Chief Medical Officer
Address: 1489 WEST WARM SPRINGS ROAD, SUITE 110, HENDERSON
Signature: /s/ Andrew Retter
Signature date: 04 Nov 2025

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

VNRX transaction

Common Stock

Tax liability

Transaction value: $1,991
Shares: -4,588
Change %: -3%
Price: $0.4340
Shares after: 146,568
Date: 01 Nov 2025
Ownership: Direct
Footnotes: F2

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F2

Represents the aggregate number of shares of common stock retained by VolitionRx for cancellation to satisfy the tax withholding obligations of the reporting person upon settlement of 9,762 restricted stock units that were awarded in lieu of cash compensation that would otherwise have been owed to the reporting person. No shares were sold by the reporting person or VolitionRx in such transaction.